ThioCORMates: Tunable and Cost-Effective Carbon Monoxide-Releasing Molecules. 2022

Catherine A DeSimone, and S Lyla Naqvi, and Sarah Z Tasker
Department of Chemistry, Franklin & Marshall College, 415 Harrisburg Ave, Lancaster, PA 17603, USA.

Carbon monoxide-releasing molecules (CORMs) can offer a safer alternative to CO delivery than the use of CO gas cylinders. Upon treatment with an amine base, S-aryl thioformates ("thioCORMates") release CO nearly quantitatively at room temperature, a gas which can then be harnessed for carbonylative cross-coupling, biological study, or inorganic synthesis. These bench-stable molecules are easily synthesized from the corresponding thiophenol and can be electronically tuned to release CO at different rates-from less than 1 min to greater than 1 h-offering a practical alternative to existing CORM technology. Finally, isotopically labeled 13 CO can be conveniently generated and used, with the thioCORMate synthesized from 13 C-formic acid.

UI MeSH Term Description Entries
D009942 Organometallic Compounds A class of compounds of the type R-M, where a C atom is joined directly to any other element except H, C, N, O, F, Cl, Br, I, or At. (Grant & Hackh's Chemical Dictionary, 5th ed) Metallo-Organic Compound,Metallo-Organic Compounds,Metalloorganic Compound,Organometallic Compound,Metalloorganic Compounds,Compound, Metallo-Organic,Compound, Metalloorganic,Compound, Organometallic,Compounds, Metallo-Organic,Compounds, Metalloorganic,Compounds, Organometallic,Metallo Organic Compound,Metallo Organic Compounds
D002248 Carbon Monoxide Carbon monoxide (CO). A poisonous colorless, odorless, tasteless gas. It combines with hemoglobin to form carboxyhemoglobin, which has no oxygen carrying capacity. The resultant oxygen deprivation causes headache, dizziness, decreased pulse and respiratory rates, unconsciousness, and death. (From Merck Index, 11th ed) Monoxide, Carbon
D003362 Cost-Benefit Analysis A method of comparing the cost of a program with its expected benefits in dollars (or other currency). The benefit-to-cost ratio is a measure of total return expected per unit of money spent. This analysis generally excludes consideration of factors that are not measured ultimately in economic terms. In contrast a cost effectiveness in general compares cost with qualitative outcomes. Cost and Benefit,Cost-Benefit Data,Benefits and Costs,Cost Benefit,Cost Benefit Analysis,Cost-Utility Analysis,Costs and Benefits,Economic Evaluation,Marginal Analysis,Analyses, Cost Benefit,Analysis, Cost Benefit,Analysis, Cost-Benefit,Analysis, Cost-Utility,Analysis, Marginal,Benefit and Cost,Cost Benefit Analyses,Cost Benefit Data,Cost Utility Analysis,Cost-Benefit Analyses,Cost-Utility Analyses,Data, Cost-Benefit,Economic Evaluations,Evaluation, Economic,Marginal Analyses

Related Publications

Catherine A DeSimone, and S Lyla Naqvi, and Sarah Z Tasker
March 2017, American journal of physiology. Cell physiology,
Catherine A DeSimone, and S Lyla Naqvi, and Sarah Z Tasker
October 2017, Organic & biomolecular chemistry,
Catherine A DeSimone, and S Lyla Naqvi, and Sarah Z Tasker
December 2022, Topics in current chemistry (Cham),
Catherine A DeSimone, and S Lyla Naqvi, and Sarah Z Tasker
November 2005, Expert opinion on investigational drugs,
Catherine A DeSimone, and S Lyla Naqvi, and Sarah Z Tasker
October 2015, ChemistryOpen,
Catherine A DeSimone, and S Lyla Naqvi, and Sarah Z Tasker
January 2003, Current pharmaceutical design,
Catherine A DeSimone, and S Lyla Naqvi, and Sarah Z Tasker
September 2012, Arteriosclerosis, thrombosis, and vascular biology,
Catherine A DeSimone, and S Lyla Naqvi, and Sarah Z Tasker
July 2006, The Journal of pharmacology and experimental therapeutics,
Catherine A DeSimone, and S Lyla Naqvi, and Sarah Z Tasker
April 2007, British journal of pharmacology,
Catherine A DeSimone, and S Lyla Naqvi, and Sarah Z Tasker
September 2017, American journal of hypertension,
Copied contents to your clipboard!